Angiotensin converting enzyme (ACE) inhibitors and their implications for the dental surgeon

British Dental Journal

Volumn 183, Issue 6, 1997, Pages 214-218

  Seymour, R A ^a   Thomason, J M ^a   Nolan, A ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HISTAMINE H1 RECEPTOR ANTAGONIST; LISINOPRIL; TERFENADINE;

ANGIONEUROTIC EDEMA; ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; FACE; FEMALE; HUMAN; LARYNX DISORDER; MALE; MIDDLE AGED; MOUTH; MOUTH DISEASE; PHARYNX DISEASE; RECURRENT DISEASE; TASTE DISORDER; TONGUE DISEASE;

ANGIONEUROTIC EDEMA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; FACE; FEMALE; HISTAMINE H1 ANTAGONISTS; HUMANS; LARYNGEAL DISEASES; LISINOPRIL; MALE; MIDDLE AGED; MOUTH DISEASES; MOUTH FLOOR; PHARYNGEAL DISEASES; RECURRENCE; TASTE DISORDERS; TERFENADINE; TONGUE DISEASES;

EID: 0031588105     PISSN: 00070610     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bdj.4809469     Document Type: Article

References (19)

1. Department of Health NHSE: Prescription Cost Analysis England 1995. Government Statistical Service 1996.
2. Alderman C P. Adverse effects of the angiotensin-converting enzyme inhibitors. Ann Pharmacother 1996; 30: 55-61.
3. Parish R C, Miller L J. Adverse effects of angiotensin converting enzyme (ACE) inhibitors. An update. Drug Safety 1992; 7: 14-31.
4. Henkin R I. Converting enzyme inhibitors in the treatment of hypertension. N Engl J Med 1989; 320: 1750-1751.
5. Neil-Dwyer G, Marus A. ACE inhibitors in hypertension, assessment of taste and smell function in clinical trials. J Hum Hyperten 1989; 3: 169-176.
6. Jett G K. Captopril-induced angioedema. Ann Emerg Med 1984; 13: 489.
7. Israeli Z H, Hall W D. Cough and angioneurotic oedema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology. Ann Intern Med 1992; 117: 234-242.
8. Thompson T, Frable A S. Drug-induced life-threatening angioedema revisited. Laryngoscope 1993; 103: 10-12.
9. Barna J S, Frable M A S. Life-threatening angioedema. Otolaryngol Head Neck Surg 1990; 103: 795-798.
10. Chin H L, Buchan D A. Severe angioedema after long-term use of an angiotensinconverting enzyme inhibitor. Ann Intern Med 1990; 112: 312-313.
11. Peacock M E, Brennan W A, Strong S L, et al. Angioedema as a complication in periodontal surgery: report of a case. J Periodontol 1991; 62: 643-646.
12. Ogbureke K U E, Cruz C, Johnson J V, HelfrickJ F. Perioperative angioedema in a patient on long-term angiotensin-converting enzyme (ACE)-inhibitor therapy. J Oral Maxillofac Surg 1996; 54: 917-920.
13. Goodfield M J, Millard L G. Severe cutaneous reactions to captopril. Br Med J (Clin Res Ed) 1985; 290: 1111.
14. Regoli D, Barabi J. Pharmacology of bradykinin and related kinins. Pharmacol Rev 1980; 32: 1-46.
15. Gannon T H, Eby T L. Angioedema from angiotensin converting enzyme inhibitors: a cause of upper airway obstruction. Laryngoscope 1990; 100: 1156-1160.
16. Pracy J P M, McGlashan J A, Walsh R M, Gleeson M J. Angioedema secondary to angiotensin-converting enzyme inhibitors. J Laryngol Otol 1994; 108: 696-698.
17. Viasses P H, Rotmensch H H, Ferguson R K, Sheaffer S L. 'Scalded mouth' caused by angiotensin- converting-enzyme inhibitors. Br Med J 1982; 284: 1672.
18. Savino L, Hauschalter H M. Lisinopril-induced 'scalded mouth syndrome'. Ann Pharmacother 1992; 26: 1381-1382.
19. Ersiev A J, Alexander J C, Boyd R L. Hematological side effects of captopril and associated risk factors. Cardiovasc Rev Rep 1982; 3: 660-671.